Home

חוץ לארץ מהורהר סבך federica tomao לערבב פנוי בעלי חיים

Triple-negative breast cancer: investigating potential molecular  therapeutic target
Triple-negative breast cancer: investigating potential molecular therapeutic target

Frontiers | A Novel PARP Inhibitor YHP-836 For the Treatment of  BRCA-Deficiency Cancers
Frontiers | A Novel PARP Inhibitor YHP-836 For the Treatment of BRCA-Deficiency Cancers

Presentazione di PowerPoint
Presentazione di PowerPoint

Risk-reducing Salpingo–Oophorectomy in Women at Higher Risk of Ovarian and  Breast Cancer: A Single Institution Prospective Ser
Risk-reducing Salpingo–Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Ser

80+ Profile mit dem Suchbegriff „Tomao“ | LinkedIn
80+ Profile mit dem Suchbegriff „Tomao“ | LinkedIn

Federica TOMAO | Researcher | Bachelor of Medicine | Sapienza University of  Rome, Rome | la sapienza | Department of Gynecology-Obstetrics & Urology
Federica TOMAO | Researcher | Bachelor of Medicine | Sapienza University of Rome, Rome | la sapienza | Department of Gynecology-Obstetrics & Urology

PDF) Uterine irradiation as a determinant of infertility and pregnancy  losses in young cancer survivors
PDF) Uterine irradiation as a determinant of infertility and pregnancy losses in young cancer survivors

Loop | Federica Tomao
Loop | Federica Tomao

Tomao - Names Encyclopedia
Tomao - Names Encyclopedia

Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer  Survivors? A Systematic Review
Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review

Expanding use of rucaparib as maintenance therapy in recurrent ovarian  cancer: updates from the ARIEL3 trial - The Lancet Oncology
Expanding use of rucaparib as maintenance therapy in recurrent ovarian cancer: updates from the ARIEL3 trial - The Lancet Oncology

A panoply of DNA repair mechanisms maintains genomic stability. DNA is... |  Download Scientific Diagram
A panoply of DNA repair mechanisms maintains genomic stability. DNA is... | Download Scientific Diagram

The puzzle of gynecologic neuroendocrine carcinomas: State of the art and  future directions - ScienceDirect
The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions - ScienceDirect

اكتشف أشهر فيديوهات federicatomo | TikTok
اكتشف أشهر فيديوهات federicatomo | TikTok

Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the  O-glycoproteome by the Macrophage Galactose-Like C-t
Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-t

Research Article FGFR4 c.1162G>A (p.Gly388Arg) Polymorphism Analysis in  Turkish Patients with Retinoblastoma
Research Article FGFR4 c.1162G>A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma

PDF) Tumor-derived microvesicles: The metastasomes | Reza Ghasemi, PhD and Federica  Tomao - Academia.edu
PDF) Tumor-derived microvesicles: The metastasomes | Reza Ghasemi, PhD and Federica Tomao - Academia.edu

Niraparib in ovarian cancer: results to date and clinical potential
Niraparib in ovarian cancer: results to date and clinical potential

PDF) Immunotherapy For Ovarian Cancer: Recent Advances And Combination  Therapeutic Approaches
PDF) Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches

Cervical Cancer: Are There Potential New Targets? An Update on Preclinical  and Clinical Results
Cervical Cancer: Are There Potential New Targets? An Update on Preclinical and Clinical Results

Journal of Experimental & Clinical Cancer Research
Journal of Experimental & Clinical Cancer Research

Angiogenesis and antiangiogenic agents in cervical cancer
Angiogenesis and antiangiogenic agents in cervical cancer

Intraperitoneal Chemotherapy by Ultrasound-Guided Direct Puncture in  Recurrent Ovarian Cancer: Feasibility, Compliance, and Comp
Intraperitoneal Chemotherapy by Ultrasound-Guided Direct Puncture in Recurrent Ovarian Cancer: Feasibility, Compliance, and Comp